Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
about
Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations.Bilateral Vestibular Deficiency: Quality of Life and Economic ImplicationsClinical Indications, Utilization, and Funding of Bariatric Surgery in Europe.Rethinking cost-effectiveness in the era of zero healthcare spending growth.Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review.
P2860
Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Illustrating potential efficie ...... llocate Medicare expenditures.
@en
type
label
Illustrating potential efficie ...... llocate Medicare expenditures.
@en
prefLabel
Illustrating potential efficie ...... llocate Medicare expenditures.
@en
P2093
P1433
P1476
Illustrating potential efficie ...... llocate Medicare expenditures.
@en
P2093
James D Chambers
Martin J Buxton
Peter J Neumann
P304
P356
10.1016/J.JVAL.2013.02.011
P577
2013-05-10T00:00:00Z